partnering

News

Almirall signs $210m bispecifics deal with EpimAb

A few months after raising €200 million in investment capital to boost its pipeline, Spanish drugmaker Almirall has used some of the cash for a bispecific antibody partner

News

Sanofi partners BioMap on AI hunt for biologic therapies

Sanofi has added another dimension to the use of artificial intelligence (AI) to seek out new drugs, partnering with BioMap on a project to find biologic therapies in a de

News

GSK to lean on Zhifei for Shingrix and maybe Arexvy in China

GSK is enlisting the aid of China’s Chongqing Zhifei Biological Products (Zhifei) to drive sales of its most important vaccine, Shingrix, in China over the next few years,

News

Sanofi buys into Teva’s anti-TL1A therapy for IBD

In its second pipeline-boosting deal in two days, Sanofi has pledged €469 million (around $490 million) upfront for rights to an anti-TL1A therapy being developed by Teva

News

Sanofi partners J&J on E. coli vaccine

Sanofi is paying $175 million upfront to claim a share of an experimental vaccine developed by Johnson & Johnson’s pharma unit Janssen that aims to tackle a major caus

News

Biogen shuts digital health unit and exits Apple alliance

Biogen has decided to close down its digital health unit, formed just two years ago, as part of a major cost-reduction drive that has already claimed thousands of jobs.

Almirall signs $210m bispecifics deal with EpimAb

Sanofi partners BioMap on AI hunt for biologic therapies

GSK to lean on Zhifei for Shingrix and maybe Arexvy in China

Sanofi buys into Teva’s anti-TL1A therapy for IBD

Sanofi partners J&J on E. coli vaccine

Biogen shuts digital health unit and exits Apple alliance

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

partnering

Editor's Picks